SGRY logo

Surgery Partners (SGRY)

Profile

Full Name

Surgery Partners, Inc.

Ticker Symbol

SGRY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

September 30, 2015

Indexes

Not included

Website

http://www.surgerypartners.com

Employees

15000

Key Details

Price

$23.26

Market Cap

$2.97B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$3.11B(+13.52% YoY)

Annual EPS

-$1.33(-1377.78% YoY)

PE Ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.26
SGRY price is $23.26

Price All-time High

$67.05
SGRY price is currently -65.31% below its historical high of $67.05

Price Most Recent Change

+4.07%
SGRY price was up +4.07% on Apr 3, 2025

Price YTD Change

+9.87%
SGRY price is up +9.87% since January 1st

Price 1-year Change

-15.39%
SGRY price is down -15.39% year-on-year

Price 3-year Change

-58.03%
SGRY price is down -58.03% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.97B
SGRY market capitalization is $2.97 billion

Market Cap 3-year Change

-40.43%
SGRY market capitalization is down -40.43% over the past 3 years

Market Cap All-time High

$5.69B
SGRY market capitalization is currently -47.84% below its historical high of $5.69 billion

Market Cap Sector Rank

86.3%
SGRY market capitalization is higher than 86.3% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.4%
SGRY shares outstanding is up +0.4% year-on-year

Shares Outstanding 3-Year Change

+41.94%
SGRY shares outstanding is up +41.94% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
SGRY beta is 0.83

200-day SMA

$26.38
SGRY price is currently -11.83% below its 200-day simple moving average

50-day SMA

$24.45
SGRY price is currently -4.86% below its 50-day simple moving average

RSI

31.77
SGRY 14-day relative strength index is 31.77

Volume

1.17
SGRY 30-day relative volume is 1.17

ATR

$0.59
SGRY average true range is $0.59

10-day Historical Volatility

16.60%
SGRY 10-day historical volatility is 16.60%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.11B
SGRY annual revenue is $3.11 billion

Revenue Analysts Estimate

$3.39B
SGRY annual revenue is currently -8.02% lower than the consensus analysts' forecast

Revenue 1-year Change

+13.52%
SGRY annual revenue is up +13.52% year-on-year

Revenue Sector Rank

89.38%
SGRY annual revenue is higher than 89.38% of companies in Healthcare sector

EPS

EPS

-$1.33
SGRY annual earnings per share is -$1.33

EPS Analysts Estimate

$1.02
SGRY annual earnings per share is currently -230.52% lower than the consensus analysts' forecast

EPS 1-year Change

-1377.78%
SGRY annual earnings per share is down -1377.78% year-on-year

EPS Sector Rank

48.69%
SGRY annual earnings per share is higher than 48.69% of companies in Healthcare sector

Profit

Gross Profit

$745.60M
SGRY annual gross profit is $745.60 million

Gross Margin

23.94%
SGRY annual gross profit margin is 23.94%

Operating Profit

$454.30M
SGRY annual operating income is $454.30 million

Operating Margin

14.59%
SGRY annual operating profit margin is 14.59%

Net Income

-$168.10M
SGRY annual net profit is -$168.10 million

Net Margin

-5.40%
SGRY annual net profit margin is -5.40%

Expenses

Total Expenses

$2.66B
SGRY annual total expenses is $2.66 billion

Operating Expenses

$291.30M
SGRY annual total operating expenses is $291.30 million

Cost Of Goods Sold

$2.37B
SGRY annual cost of goods sold is $2.37 billion

Selling, General & Administrative Expenses

$138.70M
SGRY annual SGA is $138.70 million

Depreciation And Amortization

$152.60M
SGRY annual depreciation & amortization is $152.60 million

Interest Expense

$201.70M
SGRY annual interest expense is $201.70 million

Income Tax

$134.60M
SGRY annual income tax is $134.60 million

EBIT & EBITDA

EBIT

$348.80M
SGRY annual earnings before interest & taxes is $348.80 million

EBITDA

$501.40M
SGRY annual EBITDA is $501.40 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$7.89B
SGRY annual total assets is $7.89 billion

Non Current Assets

$6.77B
SGRY annual long term assets is $6.77 billion

Current Assets

$1.12B
SGRY annual total current assets is $1.12 billion

Cash And Cash Equivalents

$269.50M
SGRY annual cash & cash equivalents is $269.50 million

Accounts Receivable

$579.10M
SGRY annual accounts receivable is $579.10 million

Inventory

$88.40M
SGRY annual inventory is $88.40 million

Liabilities

Total Liabilities

$4.25B
SGRY annual total liabilities is $4.25 billion

Long Term Liabilities

$3.63B
SGRY annual total long term liabilities is $3.63 billion

Current Liabilities

$624.40M
SGRY annual total current liabilities is $624.40 million

Accounts Payable

$208.70M
SGRY annual accounts payable is $208.70 million

Debt

Total Debt

$3.70B
SGRY annual total debt is $3.70 billion

Total Debt 1-year Change

+20.96%
SGRY annual total debt is up +20.96% year-on-year

Long Term Debt

$3.56B
SGRY annual long term debt is $3.56 billion

Short Term Debt

$142.40M
SGRY annual short term debt is $142.40 million

Equity & Capital

Shareholders Equity

$1.79B
SGRY annual stockholders equity is $1.79 billion

Book Value

$1.79B
SGRY annual book value is $1.79 billion

Retained Earnings

-$737.30M
SGRY annual retained earnings is -$737.30 million

Working Capital

$495.00M
SGRY annual working capital is $495.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$300.10M
SGRY annual cash flow from operations is $300.10 million

Cash From Operations 1-year Change

+2.14%
SGRY annual cash flow from operations is up +2.14% year-on-year

Cash From Investing

-$488.50M
SGRY annual cash flow from investing activities is -$488.50 million

Cash From Investing 1-year Change

-116.53%
SGRY annual cash flow from investing activities is down -116.53% year-on-year

Cash From Financing

$262.00M
SGRY annual cash flow from financing activities is $262.00 million

Cash From Financing 1-year Change

+268.81%
SGRY annual cash flow from financing activities is up +268.81% year-on-year

CAPEX

CAPEX

$90.40M
SGRY annual capital expenditures is $90.40 million

CAPEX 1-year Change

+1.8%
SGRY annual capital expenditures is up +1.8% year-on-year

Free Cash Flow

Free Cash Flow

$209.70M
SGRY annual free cash flow is $209.70 million

Free Cash Flow 1-year Change

+2.29%
SGRY annual free cash flow is up +2.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

23.94%
SGRY annual gross profit margin is 23.94%

Operating Margin

14.59%
SGRY annual operating profit margin is 14.59%

Net Margin

-5.40%
SGRY annual net profit margin is -5.40%

ROA & ROE

ROA

-2.28%
SGRY annual return on assets is -2.28%

ROE

-4.80%
SGRY annual return on equity is -4.80%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SGRY price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SGRY price to earnings ratio is unknown

PB Ratio

PB Ratio

1.66
SGRY price to book ratio is 1.66

PB Ratio Sector Rank

57.64%
SGRY price to book ratio is higher than 57.64% of companies in Healthcare sector

PS Ratio

PS Ratio

0.95
SGRY price to sales ratio is 0.95

PS Ratio Sector Rank

25.99%
SGRY price to sales ratio is higher than 25.99% of companies in Healthcare sector

Enterprise value

Enterprise Value

$6.40B
SGRY enterprise value is $6.40 billion

Enterprise Value Sector Rank

89.48%
SGRY enterprise value is higher than 89.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.77
SGRY EV/EBITDA is 12.77

EV/EBITDA Sector Rank

85.41%
SGRY EV/EBITDA is higher than 85.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

1.79
SGRY annual current ratio is 1.79

Quick Ratio

1.65
SGRY annual quick ratio is 1.65

Leverage

Debt To Equity

1.88
SGRY annual debt to equity ratio is 1.88

Interest Coverage Ratio

1.73
SGRY annual interest coverage ratio is 1.73

Risk & Stability

Piotroski F-Score

5
SGRY piotroski f-score is 5

Altman Z-Score

0.90
SGRY altman z-score is 0.90

Analyst ratings

Recent major analysts updates

Mar 25, 25 RBC Capital
Outperform
Mar 11, 25 Macquarie
Outperform
Dec 3, 24 JP Morgan
Neutral
Nov 20, 24 RBC Capital
Outperform
Nov 19, 24 Macquarie
Outperform
Nov 13, 24 Macquarie
Outperform
Nov 4, 24 Macquarie
Outperform
Oct 14, 24 UBS
Buy
Oct 11, 24 Keybanc
Sector Weight
Oct 4, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

MRUS logo
Merus NV (MRUS)
CPRX logo
Catalyst Pharmaceuticals (CPRX)
SHC logo
Sotera Health (SHC)
AMED logo
Amedisys (AMED)
PRCT logo
PROCEPT BioRobotics (PRCT)
Concentra Group Holdings Parent (CON)
PTGX logo
Protagonist Therapeutics (PTGX)
CRSP logo
CRISPR Therapeutics AG (CRSP)
ALVO logo
Alvotech (ALVO)
  • What is the ticker symbol for Surgery Partners?
  • Does Surgery Partners pay dividends?
  • What sector is Surgery Partners in?
  • What industry is Surgery Partners in?
  • What country is Surgery Partners based in?
  • When did Surgery Partners go public?
  • Is Surgery Partners in the S&P 500?
  • Is Surgery Partners in the NASDAQ 100?
  • Is Surgery Partners in the Dow Jones?
  • When was Surgery Partners's last earnings report?
  • When does Surgery Partners report earnings?
  • Should I buy Surgery Partners stock now?

What is the ticker symbol for Surgery Partners?

The ticker symbol for Surgery Partners is NASDAQ:SGRY

Does Surgery Partners pay dividends?

No, Surgery Partners does not pay dividends

What sector is Surgery Partners in?

Surgery Partners is in the Healthcare sector

What industry is Surgery Partners in?

Surgery Partners is in the Medical Care Facilities industry

What country is Surgery Partners based in?

Surgery Partners is headquartered in United States

When did Surgery Partners go public?

Surgery Partners's initial public offering (IPO) was on September 30, 2015

Is Surgery Partners in the S&P 500?

No, Surgery Partners is not included in the S&P 500 index

Is Surgery Partners in the NASDAQ 100?

No, Surgery Partners is not included in the NASDAQ 100 index

Is Surgery Partners in the Dow Jones?

No, Surgery Partners is not included in the Dow Jones index

When was Surgery Partners's last earnings report?

Surgery Partners's most recent earnings report was on Mar 3, 2025

When does Surgery Partners report earnings?

The next expected earnings date for Surgery Partners is May 7, 2025

Should I buy Surgery Partners stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page